Ocular Therapeutix, Inc. (NASDAQ:OCUL) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) by 48.0% in the 4th quarter, HoldingsChannel reports. The firm owned 218,588 shares of the biopharmaceutical company’s stock after purchasing an additional 70,904 shares during the period. UBS AM a […]
